Sarcomatoid carcinoma of the pancreas (Review)
- Authors:
- Yijie Ma
- Yiwen Yang
- Huizhi Zhang
- Joseph Mugaanyi
- Yangke Hu
- Shengdong Wu
- Caide Lu
- Shuqi Mao
- Ke Wang
-
Affiliations: Department of Hepatobiliary Pancreatic Surgery, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang 315048, P.R. China - Published online on: August 5, 2024 https://doi.org/10.3892/ol.2024.14610
- Article Number: 477
-
Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG and Karamouzis MV: Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol. 12:173–181. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Seok JY and Kim YB: Sarcomatoid hepatocellular carcinoma. Korean J Hepatol. 16:89–94. 2010.(In Korean). View Article : Google Scholar : PubMed/NCBI | |
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA; WHO Classification of Tumours Editorial Board, : The 2019 WHO classification of tumours of the digestive system. Histopathology. 76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Luchini C, Capelli P and Scarpa A: Pancreatic ductal adenocarcinoma and its variants. Surg Pathol Clin. 9:547–560. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bazzichetto C, Luchini C, Conciatori F, Vaccaro V, Di Cello I, Mattiolo P, Falcone I, Ferretti G, Scarpa A, Cognetti F and Milella M: Morphologic and Molecular landscape of pancreatic cancer variants as the basis of new therapeutic strategies for precision oncology. Int J Mol Sci. 21:88412020. View Article : Google Scholar : PubMed/NCBI | |
|
Higashi M, Takao S and Sato E: Sarcomatoid carcinoma of the pancreas: A case report with immunohistochemical study. Pathol Int. 49:453–456. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
De la Riva S, Muñoz-Navas MA, Betés M, Súbtil JC, Carretero C and Sola JJ: Sarcomatoid carcinoma of the pancreas and congenital choledochal cyst. Gastrointest Endosc. 64:1005–1006. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yao J, Qian JJ, Zhu CR, Bai DS and Miao Y: Laparoscopic left pancreatectomy for pancreatic sarcomatoid carcinoma: A case report and review of the literature. Oncol Lett. 6:568–570. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ren CL, Jin P, Han CX, Xiao Q, Wang DR, Shi L, Wang DX and Chen H: Unusual early-stage pancreatic sarcomatoid carcinoma. World J Gastroenterol. 19:7820–7824. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kane JR, Laskin WB, Matkowskyj KA, Villa C and Yeldandi AV: Sarcomatoid (spindle cell) carcinoma of the pancreas: A case report and review of the literature. Oncol Lett. 7:245–249. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lu BC, Wang C, Yu JH, Shen ZH and Yang JH: A huge adenosquamous carcinoma of the pancreas with sarcomatoid change: An unusual case report. World J Gastroenterol. 20:16381–16386. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yepuri N, Pruekprasert N and Naous R: High-grade malignant pancreatic neoplasm with sarcomatoid features. AME Case Rep. 2:392018. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Y, Xiang Y, Zhang D, Yao X, Sheng J, Yang Y and Zhang X: Sarcomatoid carcinoma of the pancreas: A case report and review of the literature. Mol Med Rep. 18:4716–4724. 2018.PubMed/NCBI | |
|
Bukhari N and Joudeh A: Early stage anaplastic sarcomatoid carcinoma of the pancreas, a case report. Am J Case Rep. 20:597–601. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou DK, Gao BQ, Zhang W, Qian XH, Ying LX and Wang WL: Sarcomatoid carcinoma of the pancreas: A case report. World J Clin Cases. 7:236–241. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Toledo PF, Berger Z, Carreño L, Cardenas G, Castillo J and Orellana O: Sarcomatoid carcinoma of the pancreas-a rare tumor with an uncommon presentation and course: A case report and review of literature. World J Clin Cases. 9:3716–3725. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lim HJ, Kang HS, Lee JE, Min JH, Shin KS, You SK and Kim KH: Sarcomatoid carcinoma of the pancreas-multimodality imaging findings with serial imaging follow-up: A case report and review of literature. World J Clin Cases. 9:3102–3113. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Harada Y, Sakai A, Ikegawa T, Shiomi H, Masuda A and Kodama Y: Pancreatic sarcomatoid carcinoma with intraductal growth protruding from the papilla of vater. Am J Gastroenterol. 117:19002022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang ML, Sabatino ME, Castillo CFD, Mattia AR and Chebib I: Cytologic, histologic, and molecular features of pancreatic sarcomatoid undifferentiated carcinoma with heterologous osteosarcomatous transformation. Diagn Cytopathol. 51:E164–E169. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Chen LL, Chen J, Bu P, Chen CW and Xiang XX: Two cases of sarcomatoid pancreatic carcinoma. Chin J Gastroenterol Hepatol. 23:837–838. 2014. | |
|
Hu QL, Li HQ and Xia TY: A case of sarcomatoid carcinoma of the pancreas. Shijie Huaren Xiaohua Zazhi. 23:707–710. 2015. | |
|
Zhao ZB, Ji Y and Kong HF: Pancreatic sarcomatoidcarcinoma with liver metastasis: A case report. Chin J Geriatr. 37:225–226. 2018.(In Chinese). | |
|
Jiang YS, Tao LY, Yang MW, He RZ, Shen Y and Sun YW: A case of sarcomatoid carcinoma of the pancreas. Chin J Pract Surg. 39:879–880. 2019.(In Chinese). | |
|
Ren PT: Two cases of sarcomatoid carcinoma of the pancreas. Chin J Gen Srug. 34:366–367. 2019.(In Chinese). | |
|
Kimura T, Fujimoto D, Togawa T, Ishida M, Iida A, Sato Y and Goi T: Sarcomatoid carcinoma of the pancreas with rare long-term survival: A case report. World J Surg Oncol. 18:1052020. View Article : Google Scholar : PubMed/NCBI | |
|
Kimura T, Togawa T, Iida A, Noriki S, Sato Y and Goi T: Does cellular senescence play an important role in the prognosis of sarcomatoid carcinoma of the pancreas? World J Surg Oncol. 19:792021. View Article : Google Scholar : PubMed/NCBI | |
|
Blair AB, Burkhart RA, Griffin JF, Miller JA, Weiss MJ, Cameron JL, Wolfgang CL and He J: Long-term survival after resection of sarcomatoid carcinoma of the pancreas: An updated experience. J Surg Res. 219:238–243. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gkountakos A, Simbolo M, Bariani E, Scarpa A and Luchini C: Undifferentiated sarcomatoid carcinoma of the pancreas: From histology and molecular pathology to precision oncology. Int J Mol Sci. 23:12832022. View Article : Google Scholar : PubMed/NCBI | |
|
Clark CJ, Graham RP, Arun JS, Harmsen WS and Reid-Lombardo KM: Clinical outcomes for anaplastic pancreatic cancer: A population-based study. J Am Coll Surg. 215:627–634. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Guarino M, Tricomi P, Giordano F and Cristofori E: Sarcomatoid carcinomas: Pathological and histopathogenetic considerations. Pathology. 28:298–305. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
WHO Classification of Tumours Editorial Board, . Digestive System Tumours. WHO classification of tumours. 5th edition. International Agency for Research on Cancer; Lyon: 2019 | |
|
Li J, Wei T, Zhang J, Wei S, Chen Q, Chen BW, Zhou Y, Wen L, Qin H, Bai X and Liang T: Carcinosarcoma of the pancreas: Comprehensive clinicopathological and molecular characterization. HPB (Oxford). 22:1590–1595. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Ruess DA, Kayser C, Neubauer J, Fichtner-Feigl S, Hopt UT and Wittel UA: Carcinosarcoma of the pancreas: Case report with comprehensive literature review. Pancreas. 46:1225–1233. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Thompson L, Chang B and Barsky SH: Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 20:277–285. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Cantrell LA, Blank SV and Duska LR: Uterine carcinosarcoma: A review of the literature. Gynecol Oncol. 137:581–588. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
van den Berg W, Tascilar M, Offerhaus GJ, Albores-Saavedra J, Wenig BM, Hruban RH and Gabrielson E: Pancreatic mucinous cystic neoplasms with sarcomatous stroma: Molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components. Mod Pathol. 13:86–91. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y and Weinberg RA: Epithelial-to-mesenchymal transition in cancer: Complexity and opportunities. Front Med. 12:361–373. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cantelli G, Crosas-Molist E, Georgouli M and Sanz-Moreno V: TGFBeta-induced transcription in cancer. Semin Cancer Biol. 42:60–69. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Massagué J: TGFbeta signalling in context. Nat Rev Mol Cell Biol. 13:616–630. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Arteaga CL: Inhibition of TGFbeta signaling in cancer therapy. Curr Opin Genet Dev. 16:30–37. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Massagué J: TGFbeta in cancer. Cell. 134:215–230. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and Massagué J: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA. 102:13909–13914. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Boström AK, Möller C, Nilsson E, Elfving P, Axelson H and Johansson ME: Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition. Hum Pathol. 43:708–719. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lien HC, Lee YH, Juang YL and Lu YT: Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia. Pathology. 51:375–383. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kawarada Y, Inoue Y, Kawasaki F, Fukuura K, Sato K, Tanaka T, Itoh Y and Hayashi H: TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription. Sci Rep. 6:354832016. View Article : Google Scholar : PubMed/NCBI | |
|
Saitoh M: Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression. Cancer Sci. 106:481–488. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, et al: Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 133:1317–1331. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Shi HY, Xie J and Miao F: Pancreatic carcinosarcoma: First literature report on computed tomography imaging. World J Gastroenterol. 21:1357–1361. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Watanabe M, Miura H, Inoue H, Uzuki M, Noda Y, Fujita N, Yamazaki T and Sawai T: Mixed osteoclastic/pleomorphic-type giant cell tumor of the pancreas with ductal adenocarcinoma: Histochemical and immunohistochemical study with review of the literature. Pancreas. 15:201–208. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Mugaanyi J and Lu C, Huang J and Lu C: Undifferentiated pancreatic carcinomas, clinical features and therapeutic options: What we know. Cancers (Basel). 14:61022022. View Article : Google Scholar : PubMed/NCBI | |
|
Park W, Chawla A and O'Reilly EM: Pancreatic cancer: A review. JAMA. 326:851–862. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ding Y, Shao Y, Na C, Yin JC, Hua H, Tao R, Jiang Y, Hu R, He X, Miao C, et al: Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis. J Med Genet. 59:10–17. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Gkountakos A, Mafficini A, Lou E, Malleo G, Salvia R, Calicchia M, Silvestris N, Racila E, Amin K, Veronese N, et al: Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas. Hum Pathol. 128:124–133. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM, Vilardell F, Wang Z, Keller JW, Banerjee P, et al: DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 27:1806–1813. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JCH, Leary RJ, Eshleman JR, et al: SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res. 15:4674–4679. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Agaimy A, Haller F, Frohnauer J, Schaefer IM, Ströbel P, Hartmann A, Stoehr R and Klöppel G: Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol. 28:248–260. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al: Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 518:495–501. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lehrke HD, Graham RP, Mcwilliams RR, Lam-Himlin DM, Smyrk TC, Jenkins S, Dong H and Zhang L: Undifferentiated pancreatic carcinomas display enrichment for frequency and extent of PD-L1 expression by tumor cells. Am J Clin Pathol. 148:441–449. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Silvestris N, Argentiero A, Brunetti O, Sonnessa M, Colonna F, Delcuratolo S, Luchini C, Scarpa A, Lonardi S, Nappo F, et al: PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: A pilot study. Expert Opin Ther Targets. 25:1007–1016. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Halbrook CJ, Lyssiotis CA, Pasca di Magliano M and Maitra A: Pancreatic cancer: Advances and challenges. Cell. 186:1729–1754. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Hermanek P and Wittekind C: Residual tumor (R) classification and prognosis. Semin Surg Oncol. 10:12–20. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Shiihara M, Higuchi R, Izumo W, Furukawa T and Yamamoto M: A comparison of the pathological types of undifferentiated carcinoma of the pancreas. Pancreas. 49:230–235. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Imaoka H, Ikeda M, Maehara K, Umemoto K, Ozaka M, Kobayashi S, Terashima T, Inoue H, Sakaguchi C, Tsuji K, et al: Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: A retrospective multicenter cohort study. BMC Cancer. 20:9462020. View Article : Google Scholar : PubMed/NCBI | |
|
Qian Y, Gong Y, Fan Z, Luo G, Huang Q, Deng S, Cheng H, Jin K, Ni Q, Yu X and Liu C: Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 13:1302020. View Article : Google Scholar : PubMed/NCBI | |
|
Zorde Khvalevsky E, Gabai R, Rachmut IH, Horwitz E, Brunschwig Z, Orbach A, Shemi A, Golan T, Domb AJ, Yavin E, et al: Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci USA. 110:20723–20728. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu H, Wei M, Xu J, Hua J, Liang C, Meng Q, Zhang Y, Liu J, Zhang B, Yu X and Shi S: PARP inhibitors in pancreatic cancer: Molecular mechanisms and clinical applications. Mol Cancer. 19:492020. View Article : Google Scholar : PubMed/NCBI | |
|
Ashworth A: A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol. 26:3785–3790. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S and Wei AC: Improved long-term outcomes after resection of pancreatic adenocarcinoma: A comparison between two time periods. Ann Surg Oncol. 22:1160–1167. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Philips P, Kooby DA, Maithel S, Merchant NB, Weber SM, Winslow ER, Ahmad S, Kim HJ, Scoggins CR, McMasters KM and Martin RCG II: Grading using Ki-67 index and mitotic rate increases the prognostic accuracy of pancreatic neuroendocrine tumors. Pancreas. 47:326–331. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Strobel O, Hartwig W, Bergmann F, Hinz U, Hackert T, Grenacher L, Schneider L, Fritz S, Gaida MM, Büchler MW and Werner J: Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery. 149:200–208. 2011. View Article : Google Scholar : PubMed/NCBI |
